TrialAmerican journal of clinical dermatology2025

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial.

Rodney Sinclair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.